Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma

specific

Primary peritoneal low grade serous adenocarcinoma that is resistant to treatment.

35

Centers

35

Active Trials

—

Cancer Funding

Top Centers for Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
Active Research Program
51.4
2
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
Active Research Program
51.4
3
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
51.4
4
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
51.4
5
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
51.4
6
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
51.4
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
51.4
8
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.4
9
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
51.4
10
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.4
11
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
51.4
12
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
Active Research Program
51.4
13
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
Active Research Program
51.4
14
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
51.4
15
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.4
16
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
51.4
17
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
51.4
18
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
51.4
19
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
51.4
20
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
51.4
21
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
51.4
22
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
51.4
23
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.4
24
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
Active Research Program
51.4
25
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
51.4
26
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
51.4
27
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
51.4
28
Cancer Center at IllinoisUrbana, IL
Active Research Program
51.4
29
Penn State Cancer InstituteHershey, PA
Active Research Program
51.4
30
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
51.4
31
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
51.4
32
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
Active Research Program
51.4
33
Northwell Health Cancer InstituteNew York, NY
Active Research Program
51.4
34
Upstate Cancer CenterSyracuse, NY
Active Research Program
51.4
35
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →